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Background. Although tuberculosis (TB) is a major health problem worldwide, primary extrapulmonary tuberculosis (EPTB),
and in particular female genital tract infection, remains a rare event. Case Report. A 35-year-old human immunodeﬁciency virus
(HIV) seropositive woman of African descent with lower abdominal pain and fever of two days duration underwent surgery due
to left adnexal mass suggesting pelvic inﬂammatory disease. The surgical situs showed a four quadrant peritonitis, consistent
with the clinical symptoms of the patient, provoked by a tuboovarian abscess (TOA) on the left side. All routine diagnostic
procedures failed to determine the causative organism/pathogen of the infection. Histopathological evaluation identiﬁed a
necrotic granulomatous salpingitis and speciﬁc PCR analysis corroborated Mycobacterium tuberculosis (M. Tb). Consequently,
antituberculotic therapy was provided. Conclusion. In the diﬀerential diagnosis of pelvic inﬂammatory disease, internal genital
tuberculosis should be considered. Moreover, physicians should consider tuberculous infections early in the work-up of patients
when immunosuppressive conditions are present.
Copyright © 2009 M. Ilmer et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Pelvic inﬂammatory disease (PID) is a common disorder of
the upper female genital tract that can lead to formation of
abscesses and peritonitis. In about two thirds of all reported
cases, an underlying cause cannot be identiﬁed. Otherwise, it
is often associated with sexually transmitted diseases (STDs),
such as Neisseria gonorrhoeae and Chlamydia trachomatis
infection, and is normally an ascending infection [1].
Sometimes it is facilitated by postsurgical and post-delivery
conditions or intrauterine devices (IUDs), especially shortly
after insertion. Haematogenous spread can occur but is
clinicallyrareandthereforethoughttobeofminorrelevance.
One of the worldwide major infections is tuberculosis
(TB) and particularly an increasing global health problem
with an estimated 1.7 billion infected individuals [2]. TB
becomes manifest primarily in the lungs, although extra-
pulmonary infections are also observed. However, extrapul-
monary infections, such as primary genital tuberculosis, are
n o tv e r yc o m m o ni nd e v e l o p e dc o u n t r i e s[ 3]. Histologically,
granulomatous inﬂammatory reactions and caseating and
noncaseating granulomas characterize tuberculous infec-
tions. Lymphatic and haematogenous dissemination to parts
of the body other than the lung is possible.
Underlying immunosuppressive diseases favor oppor-
tunistic infections and can be associated with pelvic inﬂam-
matory disease (PID) in these patients. In this regard, the
best-known sexually transmitted pathogen is the retrovirus
human immunodeﬁciency virus (HIV). Main targets of
this pathogenic agent are CD4+ T cells, helper T cells,
as well as macrophages and dendritic cells, resulting in
a signiﬁcant decline of CD4+ T cell populations [4]. An
HIV infection makes patients more susceptible for further
gynaecological infectious diseases including tuberculosis due
to their immunosuppressed status [5, 6].
Here,wepresentacaseabouta35-year-old,HIV-positive
patient admitted to our hospital with fever and pain in the
lower left abdominal quadrant, with a tuboovarial abscess
caused by Mycobacterium tuberculosis (M. Tb).
2.CaseReport
A 35-year-old woman of African descent with chronic
alcohol and nicotine abuse was admitted to our hospital in2 Infectious Diseases in Obstetrics and Gynecology
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Figure 1: Ultrasound ﬁndings. On ultrasound examination a 5 ×
6cm cystic mass lesion in the area of the left fallopian tube could be
displayed.
November 2007 with a two-day history of lower left-sided
abdominal pain as well as febrile temperatures of 38.8
◦Ca n d
elevated inﬂammation parameters. Her past medical history
included HIV infection that was ﬁrst diagnosed in 2001
and treated with a combination of lamivudin 150mg plus
zidovudin 300mg (Combivir) and efavirenz 50mg/200mg
(Sustiva). In that same year, the patient underwent surgery
(a longitudinal incision laparotomy) for an ovarian cyst. The
patient did not tolerate antiretroviral treatment (due to side
eﬀects) and stopped taking her HIV medication in 2006, one
year prior to her current admission. In November 2007, the
viral load was 59.000copies/mL and CD4 count was 13%
or 159cells/μL. As a secondary ﬁnding, a chronic hepatitis
B infection with a low viral load was detected during this
hospitalization,whereasahepatitisCinfectionwasexcluded.
A prior history of tuberculosis was denied by the patient.
On ultrasound examination a 5 × 6cm cystic mass
lesion in the area of the left adnexa could be displayed
(Figure 1).Severalsurgicalproceduresincludinglaparoscopy
with subsequent drainage, laparotomy, exstirpation of the
cyst, and one-sided ovarectomy were discussed with the
patient. First, a diagnostic laparoscopy was performed,
revealing several intraabdominal adhesions of the intestine
as well as a severe pus-ﬁlled abdominal cavity. Therefore, a
median longitudinal laparotomy had to be performed. After
(a)
(b)
Figure 2: Haematoxylin and Eosin (HE) Staining of the left fallop-
ian tube: (a) low magniﬁcation, and (b) high magniﬁcation. Diﬀuse
Central necrosis and caseation with epithelioid and multinucleated
giant cell (Langerhans) inﬁltration are shown.
taking microbial samples, abdominal adhesions were divided
and extensively rinsed. Afterwards, a tubectomy on the left
side was performed and a drainage system was inserted.
Following the operation, an intravenous antibiotic therapy
with ciproﬂoxacin and metronidazol was started and the
pelvis minor was rinsed twice daily. Afterwards, the patient
recovered quickly from the surgical intervention. Ten days
later, the patient was discharged from the hospital in a good
general state of health.
Due to the known HIV-infection, detailed analysis of
pus obtained during the operation was necessary. In spite of
this, cultures for aerobic and anaerobic microbes, cultures of
Mycobacteriumtuberculosis,as well as Chlamydia trachomatis
andChlamydiapneumoniae werenegative.Histopathological
studies showed a granulomatous salpingitis with central
necrosis of the left fallopian tube (Figure 2) and subsequent
PCRdemonstratedevidenceforM.Tb-complexspeciﬁcPCR
products. Special stains (Ziehl-Neels en and Auramin) for
acid-fast organisms remained negative. Interestingly, chest
X-ray analysis performed days after the surgical procedure
did not demonstrate any signs of tuberculous involvement of
the lung.
Because of her underlying HIV disease, the patient
was referred to our infectious diseases unit and was
treated according to current recommendations [7]w i t hInfectious Diseases in Obstetrics and Gynecology 3
a standardized short-course chemotherapeutic regimen of
isoniazid/vitamin B and rifampicin for 6 months and pyraz-
inamid and ethambutol for 2 months. Due to her low CD4
counts (170cells/μL = 12%) prophylactic antibiotic therapy
with cotrimoxazole was initiated (this has been shown to
decrease mortality in HIV/TB- coinfected patients [8]). She
responded promptly to antibiotic therapy as evidenced by
declining liver enzymes and CRP after two, three, and seven
weeks, respectively. Her WBC remained constant within
commonly accepted limits.
Initiation of an antiretroviral treatment (ART) against
HIV was to be started at a later time point (between 2
weeks and 2 months later) in order to not interfere with
tuberculosis regimens [9].
3. Discussion
Tuberculosis is a global burden since one-third of the world’s
population is estimated to be infected with Mycobacterium
tuberculosis [10]. By contrast, extrapulmonary tuberculosis
(EPTB) is less frequently found than pulmonary tuber-
culosis. Moreover, it is very rarely the cause of pelvic
inﬂammatory disease in developed countries. There are
several risk factors for EPTB and tuberculosis of the female
genital tract. Most of these are host factors causing impaired
immunity, whereas increased exposure to the infection
is also considered to be a risk factor. Genital tract TB
is more likely in non-Hispanic black patients, patients
under 40 years of age [11], and patients with a history
of alcoholism (alcohol abuse) [12]. But one of the major
risk factors is HIV-infection [13]. In fact, in developed
countries extrapulmonary tuberculosis in the setting of HIV
infection is classiﬁed as an AIDS-deﬁning condition (stage 4)
[10]. Further, patients with CD4 counts <200cells/μLa r ea t
substantially higher risk of tuberculosis compared to those
with higher counts [10].
Genital tuberculosis (GTB) is found in about 1% of
all tuberculosis positive patients [14]. Secondary infection
by haematogenous spread causes the majority of GTB
[5], but rare occurrences of primary inoculation during
sexual intercourse with an infected partner suﬀering from
tuberculous lesions of genitalia are reported. In almost 100%
of the cases, the fallopian tubes are aﬀected, followed by
endometrial (50%) and ovarian involvement (20%), whereas
infection of the external genitalia occurs in less than 5%
of cases [11]. Usually, these patients present with a history
of involuntary infertility [15, 16], uterine haemorrhage [11,
17], or typical symptoms of PID like pelvic pain, fever, and
menstrual disturbances or vaginal discharge [3, 11, 15–17].
Patients suﬀering from immunosuppressive diseases like
HIV, aplastic anaemia, and alcoholism are considered at
high risk for genital tuberculosis. The diagnosis of GTB
is a clinical challenge and is rarely pin-pointed by clinical
symptoms because of their low speciﬁcity. Moreover, elabo-
rate examinations (pelvic ultrasound, chest X-ray, Mantoux
test, bacteriological cultivation, Ziehl-Neelson staining for
Acid Fast Bacilli, PCR analysis, pathohistologic evaluation)
including invasive surgical procedures such as diagnostic
laparoscopy often have to be carried out for diagnosing
TB. However, even negative results cannot rule out a
tuberculous infection, since up to 92% of chest X-rays,
over 90% of Ziehl-Neels on stains and even pathological
examinations can be negative in a patient with tuberculosis
infection.Interestingly,themostlikelyreasonfortheabsence
of pulmonary abnormalities is that in immunocompetent
patients most lesions of primary and disseminated TB can
heal. However, the remaining cavities can be potential foci
of a later reactivation or may even be the cause of spreading
through the blood stream [18]. This case report illustrates
that patients with impaired immunity might also have an
EPTB manifestation without a subsequent focus. Current
treatment recommendations include isoniazid, rifampin,
andpyrazinamideasbasicregimencomplementedusuallyby
ethambutol as a fourth agent for a 2-month period and the
ﬁrst two agents for an additional 4 months [7]. Nonetheless,
genitourinary tuberculosis has been reported to have high
rate of treatment failure, particularly in advanced stages of
the disease [3].
Therefore, every attending gynaecological physician
should be aware of the possibility of tuberculosis as a cause
of pelvic inﬂammatory disease (PID). In patients with risk
factors such as HIV-positivity, alcoholism, intravenous drug
abuse(IVDA), and otherimmunosuppressive diseases, tubo-
ovarian abscesses (TOA) caused by tuberculous pathogens
should be considered [6].
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